Till Eichenauer
Impact in
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
-
- Cancer Immunotherapy and Biomarkers
- Bone health and treatments
Papers in
-
- Renal cell carcinoma treatment 10
- Prostate Cancer Treatment and Research 7
- Prostate Cancer Diagnosis and Treatment 2
-
- Hippo pathway signaling and YAP/TAZ 1
- Co-authors
- Ronald Simon (10 shared papers)Guido Sauter (11 shared papers)Michael Rink (8 shared papers)Waldemar Wilczak (7 shared papers)Margit Fisch (8 shared papers)Stefan A. Steurer (5 shared papers)Franziska Büscheck (8 shared papers)Hartwig Huland (3 shared papers)
In The Last Decade
Till Eichenauer
20 papers receiving 370 citations
Peers
Comparison fields: 5 of 42
- Pulmonary and Respiratory Medicine 209
- Oncology 75
- Cancer Research 26
- Cell Biology 24
- Molecular Biology 53
Countries citing papers authored by Till Eichenauer
This map shows the geographic impact of Till Eichenauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Till Eichenauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Till Eichenauer more than expected).
Fields of papers citing papers by Till Eichenauer
This network shows the impact of papers produced by Till Eichenauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Till Eichenauer. The network helps show where Till Eichenauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Till Eichenauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 116 | |
| 2 | 2021 | 31 | |
| 3 | 2018 | 28 | |
| 4 | 2021 | 26 | |
| 5 | 2016 | 24 | |
| 6 | 2020 | 24 | |
| 7 | 2016 | 23 | |
| 8 | 2020 | 20 | |
| 9 | 2021 | 19 | |
| 10 | 2020 | 17 | |
| 11 | 2019 | 11 | |
| 12 | 2019 | 8 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 3 | |
| 16 | 2020 | 3 | |
| 17 | 2020 | 3 | |
| 18 | 2014 | 2 | |
| 19 | 2019 | 2 | |
| 20 | 2022 | 2 |
About Till Eichenauer
Till Eichenauer is a scholar working on Pulmonary and Respiratory Medicine, Cell Biology, Oncology, Surgery and Nuclear Energy and Engineering, having authored 20 papers that have together received 376 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (10 papers), Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Bladder and Urothelial Cancer Treatments (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Hippo pathway signaling and YAP/TAZ (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (209 citations), Oncology (75 citations), Cancer Research (26 citations), Cell Biology (24 citations) and Molecular Biology (53 citations). Till Eichenauer has collaborated with scholars based in Germany and Sweden. Frequent co-authors include Ronald Simon, Guido Sauter, Michael Rink, Waldemar Wilczak, Margit Fisch, Stefan A. Steurer, Franziska Büscheck, Hartwig Huland, Sarah Jane Pauline Minner and Christoph Fraune. Their work appears in journals such as Urologic Oncology Seminars and Original Investigations, World Journal of Urology, Oncotarget, The Journal of Pathology and World Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.